Epithelial Growth Factor Receptor Inhibitors for treatment of recurrent or progressive high grade glioma: an exploratory study. (Q46610505)

From Wikidata

Jump to navigation Jump to search

scientific article published on 6 May 2008

edit

Language	Label	Description	Also known as
English	Epithelial Growth Factor Receptor Inhibitors for treatment of recurrent or progressive high grade glioma: an exploratory study.	scientific article published on 6 May 2008

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18458820

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18458820%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

title

Epithelial Growth Factor Receptor Inhibitors for treatment of recurrent or progressive high grade glioma: an exploratory study (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18458820

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18458820%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

author

Matthias Preusser

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18458820

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18458820%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

Georg Widhalm

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18458820

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18458820%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

author name string

E Gelpi

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18458820

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18458820%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

A Rottenfusser

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18458820

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18458820%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

K Dieckmann

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18458820

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18458820%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

W Dietrich

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18458820

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18458820%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

A Bertalanffy

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18458820

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18458820%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

D Prayer

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18458820

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18458820%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

J A Hainfellner

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18458820

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18458820%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

Christine Marosi

series ordinal

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18458820

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18458820%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

publication date

6 May 2008

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18458820

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18458820%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

published in

Journal of Neuro-Oncology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18458820

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18458820%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

volume

89

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18458820

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18458820%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18458820

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18458820%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

page(s)

211-218

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18458820

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18458820%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

cites work

Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11060-008-9608-3

retrieved

21 January 2018

Phase I trial of erlotinib with radiation therapy in patients with glioblastoma multiforme: results of North Central Cancer Treatment Group protocol N0177.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11060-008-9608-3

retrieved

21 January 2018

EGFR tyrosine kinase domain mutations in human gliomas

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11060-008-9608-3

retrieved

21 January 2018

Dermatologic side effects associated with the epidermal growth factor receptor inhibitors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18458820

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic pathways to primary and secondary glioblastoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18458820

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18458820

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glioblastoma multiforme and the epidermal growth factor receptor

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18458820

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18458820

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18458820

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EGFR targeting of solid tumors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18458820

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resistance to tyrosine kinase inhibition by mutant epidermal growth factor receptor variant III contributes to the neoplastic phenotype of glioblastoma multiforme

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18458820

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18458820

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EGF mutant receptor vIII as a molecular target in cancer therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18458820

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of gefitinib in recurrent glioblastoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18458820

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18458820

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18458820

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18458820

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma patients in vivo

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18458820

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changing paradigms--an update on the multidisciplinary management of malignant glioma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18458820

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between development of rash and efficacy in patients treated with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in two large phase III studies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18458820

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Erlotinib in cancer treatment.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18458820

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor receptor (EGFR) signaling in cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18458820

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18458820

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Erlotinib in gliomas: should selection be based on EGFR and Akt analyses?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18458820

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER1/EGFR tyrosine kinase inhibitors for the treatment of glioblastoma multiforme

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18458820

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor receptor inhibition for the treatment of glioblastoma multiforme and other malignant brain tumours

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18458820

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18458820

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18458820

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S11060-008-9608-3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18458820

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18458820%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

PubMed publication ID

18458820

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18458820

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18458820%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46610505&oldid=2207978027"